^
BIOMARKER:

MET positive

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Entrez ID:
MET positive
Solid Tumor
GST-HG16
Sensitive: C2 – Inclusion Criteria
MET positive
NSCLC
ABBV-399
Sensitive: C2 – Inclusion Criteria
MET positive
SCCHN
nivolumab
Resistant: C3 – Early Trials
MET positive
Lung Non-Squamous Non-Small Cell Cancer
erlotinib + ABBV-399
Sensitive: C3 – Early Trials
MET positive
Lung Non-Small Cell Squamous Cancer
erlotinib + ABBV-399
Sensitive: C3 – Early Trials